Home » Biostar Receives Approval for Advertising of Hepatitis B Drug in Shaanxi Province
Biostar Receives Approval for Advertising of Hepatitis B Drug in Shaanxi Province
Drugmaker Biostar Pharmaceuticals said Tuesday it received new marketing approval for an over-the-counter hepatitis B drug, its main product, in China’s Shaanxi province.
CB Online
CB Online
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May